Evidence map›Paper›PMID 24486130›Full record

ArticleExperimental gerontology2014

Joint inhibition of TOR and JNK pathways interacts to extend the lifespan of Brachionus manjavacas (Rotifera).

Terry W Snell, Rachel K Johnston, Brett Rabeneck, Cody Zipperer, Stephanie Teat

Open access · hybridAbstract read
In one paragraph

Article in Experimental gerontology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 41 citations in OpenAlex.

  1. c-Jun N-terminal kinase signaling in aging.Frontiers in aging neuroscience · 2024
    Review
  2. Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Invertebrates as model organisms for research on aging biology.Invertebrate reproduction & development · 2015
    Article
  16. Rotifers as experimental tools for investigating aging.Invertebrate reproduction & development · 2015
    Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Terry W SnellSchool of Biology, Georgia Institute of Technology, Atlanta, GA 30332-0230, USA. Electronic address: terry.snell@biology.gatech.edu.
Rachel K JohnstonSchool of Biology, Georgia Institute of Technology, Atlanta, GA 30332-0230, USA.
Brett RabeneckSchool of Biology, Georgia Institute of Technology, Atlanta, GA 30332-0230, USA.
Cody ZippererSchool of Biology, Georgia Institute of Technology, Atlanta, GA 30332-0230, USA.
Stephanie TeatSchool of Biology, Georgia Institute of Technology, Atlanta, GA 30332-0230, USA.
Georgia Institute of Technology · US

Funding

Monogonont Rotifers as a Model to Investigate the Biology of AgingR01AG037960 · NIA · GEORGIA INSTITUTE OF TECHNOLOGY · PI SNELL, TERRY W · 2010 to 2014
$1.4M
NIA NIH HHS R01 AG037960NIA NIH HHS R01 AG037960-02
6 · The paper itself

Abstract

The TOR kinase pathway is central in modulating aging in a variety of animal models. The target of rapamycin (TOR) integrates a complex network of signals from growth conditions, nutrient availability, energy status, and physiological stresses and matches an organism's growth rate to the resource environment. Important remaining problems are the identification of the pathways that interact with TOR and their characterization as additive or synergistic. One of the most versatile stress sensors in metazoans is the Jun-N-terminal kinase (JNK) signaling pathway. JNK is an evolutionarily conserved stress-activated protein kinase that is induced by a range of stressors, including UV irradiation, reactive oxygen species, DNA damage, heat, and bacterial antigens. JNK is thought to interact with the TOR pathway, but its effects on TOR are poorly understood. We used the rotifer Brachionus manjavacas as a model animal to probe the regulation of TOR and JNK pathways and explore their interaction. The effect of various chemical inhibitors was examined in life table and stressor challenge experiments. A survey of 12 inhibitors revealed two, rapamycin and JNK inhibitor, that significantly extended lifespan of B. manjavacas. At 1 μM concentration, exposure to rapamycin or JNK inhibitor extended mean rotifer lifespan by 35% and maximum lifespan by 37%. Exposure to both rapamycin and JNK inhibitor simultaneously extended mean rotifer lifespan by 65% more than either alone. Exposure to a combination of rapamycin and JNK inhibitors conveyed greater protection to starvation, UV and osmotic stress than either inhibitor alone. RNAi knockdown of TOR and JNK gene expression was investigated for its ability to extend rotifer lifespan. RNAi knockdown of the TOR gene resulted in 29% extension of the mean lifespan compared to control and knockdown of the JNK gene resulted in 51% mean lifespan extension. In addition to the lifespan, we quantified mitochondria activity using the fluorescent marker MitoTracker and lysosome activity using LysoTracker. Treatment of rotifers with JNK inhibitor enhanced mitochondria activity nearly 3-fold, whereas rapamycin treatment had no significant effect. Treatment of rotifers with rapamycin or JNK inhibitor reduced lysosome activity in 1, 3 and 8 day old animals, but treatment with both inhibitors did not produce any additive effect. We conclude that inhibition of TOR and JNK pathways significantly extends the lifespan of B. manjavacas. These pathways interact so that inhibition of both simultaneously acts additively to extend rotifer lifespan more than the inhibition of either alone.

Indexed as

AgingAnimalsJNK Mitogen-Activated Protein KinasesMAP Kinase Signaling SystemRotiferaSirolimusTOR Serine-Threonine KinasesJNK Mitogen-Activated Protein KinasesSirolimusTOR Serine-Threonine KinasesJNKLifespanLysosomesMitochondriaSwimmingTOR

Identifiers

PMID24486130
PMCPMC3970784
OpenAlexW2092339753

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.